Exact Mass: 369.0629

Exact Mass Matches: 369.0629

Found 28 metabolites which its exact mass value is equals to given mass value 369.0629, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

O1-(2-Thienylcarbonyl)-3-[(2-pyridylthio)methyl]benzene-1-carbohydroximamide

O1-(2-Thienylcarbonyl)-3-[(2-pyridylthio)methyl]benzene-1-carbohydroximamide

C18H15N3O2S2 (369.0606)


   

Bismuth subsalicylate

Bismuth subsalicylate

C7H12BiO4+2 (369.0539)


   

gamma-glutamylcystine

gamma-glutamylcystine

C11H19N3O7S2 (369.0664)


   

4-Pyridinol, 2-[[[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfinyl]methyl]-3-methoxy-

4-Pyridinol, 2-[[[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfinyl]methyl]-3-methoxy-

C15H13F2N3O4S (369.0595)


   

(r,r)-7-amino-3-(1-methylpyrrolidinio)methyl-3-cephem-4-carboxylate hcl

(r,r)-7-amino-3-(1-methylpyrrolidinio)methyl-3-cephem-4-carboxylate hcl

C13H21Cl2N3O3S (369.0681)


   

(2-((4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)-4-(PYRIDIN-4-YL)THIAZOL-5-YL)METHANOL

(2-((4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)-4-(PYRIDIN-4-YL)THIAZOL-5-YL)METHANOL

C16H11F4N3OS (369.0559)


   

4-(4-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

4-(4-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

C16H20BrNO4 (369.0576)


   

Boc-trans-DL-b-Pro-4-(3-bromophenyl)-OH

Boc-trans-DL-b-Pro-4-(3-bromophenyl)-OH

C16H20BrNO4 (369.0576)


   

Felodipine 3,5-Dimethyl Ester

Felodipine 3,5-Dimethyl Ester

C17H17Cl2NO4 (369.0535)


   

Dimethyl 4-(3,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyri dinedicarboxylate

Dimethyl 4-(3,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyri dinedicarboxylate

C17H17Cl2NO4 (369.0535)


   

SDZ 220-581

SDZ 220-581

C16H17ClNO5P (369.0533)


SDZ 220-581 is an orally active, potent, competitive NMDA receptor antagonist with pKi value of 7.7[1].

   

(5-Bromo-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone

(5-Bromo-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone

C20H20BrNO (369.0728)


   

4-(2-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

4-(2-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

C16H20BrNO4 (369.0576)


   

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid

C19H13ClFN3O2 (369.068)


   

(Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)-N-((5-Methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl)Methyl)acetaMide

(Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)-N-((5-Methyl-7-oxo-2,4,5,7-tetrahydro-1H-furo[3,4-d][1,3]thiazin-2-yl)Methyl)acetaMide

C13H15N5O4S2 (369.0565)


   

Tris(Cyclopentadienyl)Ytterbium(Iii)

Tris(Cyclopentadienyl)Ytterbium(Iii)

C15H15Yb (369.0562)


   

5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H13Cl2N5 (369.0548)


   

2-[[[1-(2-Methoxy-5-methylphenyl)-5-tetrazolyl]thio]methyl]-1,3-benzothiazole

2-[[[1-(2-Methoxy-5-methylphenyl)-5-tetrazolyl]thio]methyl]-1,3-benzothiazole

C17H15N5OS2 (369.0718)


   

N-{[3-(4-chlorophenyl)-1H-pyrazol-4-yl]methylene}-4-nitrobenzohydrazide

N-{[3-(4-chlorophenyl)-1H-pyrazol-4-yl]methylene}-4-nitrobenzohydrazide

C17H12ClN5O3 (369.0629)


   

3-(2-furyl)-N-({[4-(4-methylphenyl)-1,3-thiazol-2-yl]amino}carbonothioyl)acrylamide

3-(2-furyl)-N-({[4-(4-methylphenyl)-1,3-thiazol-2-yl]amino}carbonothioyl)acrylamide

C18H15N3O2S2 (369.0606)


   

SMS2-IN-2

SMS2-IN-2

C19H13ClFN3O2 (369.068)


SMS2-IN-2 is a potent, highly selective and orally active sphingomyelin synthase 2 (SMS2) inhibitor, with IC50s of 100 nM and 56 μM for SMS2 and SMS1, respectively. Anti-chronic inflammatory activity[1].

   

α-NETA

α-NETA

C16H20INO (369.059)


α-NETA is a potent and noncompetitive choline acetyltransferase (ChA) inhibitor with an IC50 of 9 μM. α-NETA is a potent ALDH1A1 (IC50=0.04 μM) and chemokine-like receptor-1 (CMKLR1) antagonist. α-NETA weakly inhibits cholinesterase (ChE; IC50=84 μM) and acetylcholinesterase (AChE; IC50=300 μM). α-NETA has anti-cancer activity[1][2].

   

1-chloro-n-[2-chloro-5-(3-chloro-2,2-dimethyl-6-methylidenecyclohexyl)-3-methylidenepentyl]methanecarbonimidoyl chloride

1-chloro-n-[2-chloro-5-(3-chloro-2,2-dimethyl-6-methylidenecyclohexyl)-3-methylidenepentyl]methanecarbonimidoyl chloride

C16H23Cl4N (369.0585)


   

1-chloro-n-[(2s)-2-chloro-5-[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylidenepentyl]methanecarbonimidoyl chloride

1-chloro-n-[(2s)-2-chloro-5-[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylidenepentyl]methanecarbonimidoyl chloride

C16H23Cl4N (369.0585)


   

(2s)-2-amino-4-{[(1r)-2-{[(2r)-2-amino-2-carboxyethyl]disulfanyl}-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-2-{[(2r)-2-amino-2-carboxyethyl]disulfanyl}-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid

C11H19N3O7S2 (369.0664)


   

1-chloro-n-{2-chloro-5-[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylidenepentyl}methanecarbonimidoyl chloride

1-chloro-n-{2-chloro-5-[(1r,3s)-3-chloro-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylidenepentyl}methanecarbonimidoyl chloride

C16H23Cl4N (369.0585)


   

2-amino-4-({2-[(2-amino-2-carboxyethyl)disulfanyl]-1-carboxyethyl}-c-hydroxycarbonimidoyl)butanoic acid

2-amino-4-({2-[(2-amino-2-carboxyethyl)disulfanyl]-1-carboxyethyl}-c-hydroxycarbonimidoyl)butanoic acid

C11H19N3O7S2 (369.0664)